More on WGS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-128.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GeneDx Holdings (NQ:WGS)
Delayed: 60.54 +1.44 (2.44%)
Prev. Close $59.10  
Open$59.37 
52 Wk High$ 
52 Wk Low$ 
Day High$61.65 
Day Low$59.06 
P/E N/A  
EPS$ 
Volume611,523 

Friends, Peers and Foes (?): GRAL, VRRM, BMI, NAVN, SEER (more...)

Jul 27, 2026 02:47 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 24, 2026 05:23 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 22, 2026 04:54 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 21, 2026 04:08 PM Form 25-NSE GeneDx Holdings Corp. Filed by: Nasdaq Stock Market LLC
Jul 20, 2026 03:48 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 17, 2026 04:31 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 16, 2026 04:05 PM GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
Jul 8, 2026 10:07 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 7, 2026 03:13 PM GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Jul 7, 2026 08:19 AM Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI) (F
View All Articles